v3.24.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Revenue $ 9,936 $ 14,880
Operating expenses:    
Research and development 108,153 111,944
General and administrative 28,282 29,299
Transaction related expenses   9,510
Restructuring (Note 14) 2,489  
Total operating expenses 138,924 150,753
Loss from operations (128,988) (135,873)
Interest income 6,816 2,132
Interest expense (5,127) (4,134)
Change in fair value of warrant liabilities (37,275) 43,221
Net loss applicable to common stockholders $ (164,574) $ (94,654)
Net loss per share applicable to common stockholders - basic $ (5.81) $ (7.49)
Net loss per share applicable to common stockholders - diluted $ (5.81) $ (7.49)
Weighted-average number of common shares used in net loss per share applicable to common stockholders - basic 28,325,779 12,631,968
Weighted-average number of common shares used in net loss per share applicable to common stockholders - diluted 28,325,779 12,631,968

Source